PPD
PPD is a leading global CRO providing comprehensive, integrated drug development, laboratory and lifecycle management services, as well as evidence-based solutions to demonstrate real-world effectiveness, safety, and value through our Evidera business unit. Hematology and oncology form one of PPD’s leading therapeutic areas, with over 1400 studies conducted in the last five years. This experience, coupled with our global networks of investigators and payers, expedites trial startups and optimizes market access to help our clients deliver life-changing therapies.